Skip to content
Sign in
SWC 2026 FinalistGrand Final: Main Stage

Hi Doctor

Physician-built Kyrgyz AI ecosystem combining clinical decision support, voice documentation and virtual-patient simulation, piloted in Astana Smart City.

Bishkek, Kyrgyzstan, AsiaHealthTech, AI-based medical education and clinical simulationKyrgyzstan (regional final 2026, winner)
Stage
Self-fundedAI at the core
Product
PilotPilots / LOIs
Funding raised
Undisclosedno funding
Founded
20197 years ago
Founders
1Nursultan
Global score
4.0Grade DRank 89 of 151

Overview

Hi Doctor (HiDoctor) is a Kyrgyz medical AI start-up founded by a physician: an ecosystem for doctors (automated medical workstation, AI clinical decision support assistant, voice assistant that generates medical documents, telemedicine with video-based vital sign analysis "NORAi") and an "AI-native" medical education platform with virtual patients for clinical reasoning training. Pilot in a clinic in Astana (Smart City).

Traction

Pilots / LOIs

Pilot among the 10 projects of the Astana Smart City program (Astana Hub / Astana Innovations); simulation tested at the simulation center of the Kyrgyz State Medical Academy (97% reported satisfaction); used by doctors and clinics in Kyrgyzstan and Kazakhstan according to the press (April 2025), with no user figures.

Market

Medical simulation and clinical training

Central Asian health systems face doctor shortages and heavy documentation burdens, and medical schools need simulation tools. AI assistants and virtual patients can address both. Buyers are clinics, governments and medical academies. Revenue is not yet proven and international competition is strong.

Addressable market

2025
$2.1B
2030
$3.9B
+13.33% a year

Medical simulation and clinical training: $2.06bn in 2025, +13.33%/year, $3.85bn in 2030 (Knowledge Sourcing).

Customers

Doctors and clinics, medical academies, smart-city programmes

Who signs the cheque

Clinic owners, ministries/city programmes, medical school directors

Geographies

  • Kyrgyzstan
  • Kazakhstan

Drivers

  • Doctor shortages
  • Documentation burden
  • Medical education digitisation

Headwinds

  • No proven revenue
  • Health regulation
  • Competition

Knowledge Sourcing estimates medical simulation at $2.06bn in 2025 and $3.85bn in 2030 (CAGR 13.3%); other studies $1.9–2.7bn.

Scalability 7/10. AI software deployable online, but language, clinical and regulatory adaptation needed outside Central Asia.

Market source: knowledge-sourcing.com

Technology

Category

Healthcare AI software

AI at the coreGenerative AI / LLMLanguage / voice processingComputer vision

Maturity

  1. R&D
  2. Prototype
  3. Pilot
  4. On the market
  5. Scaling

pilot

How it works

AI supports clinical decisions and generates documents from voice; NORAi analyses vital signs from video. A simulator generates virtual patients that evolve with user decisions.

Moat

Weak-to-moderate: local language and clinical workflow knowledge.

Differentiation

Combines clinical tools and education in one ecosystem for Central Asia.

Integration points

  • Clinic systems
  • Telemedicine platforms
  • Medical education
  • Screening AI

Depends on

  • LLM providers
  • Regulation
  • Clinic adoption

Use of AI

AI clinical decision support assistant, voice dictation that generates documents, video-based vital sign analysis and AI-generated virtual patients.

Product in detail

AI for clinical decision support and document automation (speech recognition); video-based vital sign analysis (NORAi); clinical simulator with AI-generated virtual patients that evolve according to the user's decisions.

Business

Model
Software subscriptions for doctors/clinics and education (monetisation since 2024).
Revenue logic
Per-user subscriptions (not disclosed).
Go-to-market
Pilots with Astana Hub and medical academies.

Next milestones

  1. Paying clinic customers
  2. Government contract
  3. Seed round

Key risks

  • No revenue evidence
  • Self-funded
  • Narrow market

Opportunities

4 found in the network

Concrete moves for Hi Doctor inside the network: who to sell to, sell through, build with or raise from, each with the reasoning, the evidence and the first step.

  • Distribution 1
  • Co-development 2
  • Investors 1

Distribution1

A channel or customer base to reach together

Explore a white-label partnership for Central Asia

TIBOK distributes its AI healthcare OS under partners' brands with a workspace per country and language; Hi Doctor has local clinic relationships in Kyrgyzstan and Kazakhstan. A partnership could combine TIBOK's platform with Hi Doctor's local presence.

20%confidence

Evidence from the records

  • “distribute it under their own brand, on their own WhatsApp and phone numbers, with one workspace per client (country, language, time zone)”
  • “used by doctors and clinics in Kyrgyzstan and Kazakhstan according to the press (April 2025), with no user figures.”
If it works
A Central Asian distribution agreement.
First step
Arrange a founder call to compare offerings.

Co-development2

An integration or joint product

Bundle virtual labs with virtual patients for medical schools

Medical schools buy both lab and clinical simulation. PraxiLabs brings a large user base and university customers; Hi Doctor brings AI virtual patients.

30%confidence

Evidence from the records

  • “Claims more than 2.5 million users in more than 160 countries; university customers such as IE University and Texas A&M.”
  • “clinical simulator with AI-generated virtual patients that evolve according to the user's decisions.”
If it works
A joint offer for medical faculties.
First step
Arrange a call with PraxiLabs' CEO.

Add anemia screening to NORAi video vital-sign analysis

Hi Doctor's telemedicine already analyses vital signs from video; Monere screens for anemia from a smartphone eyelid photo. Integrating both increases screening value.

25%confidence

Evidence from the records

  • “AI-assisted non-invasive anemia screening (technical details not published).”
  • “telemedicine with video-based vital sign analysis "NORAi"”
If it works
A richer telemedicine screening package.
First step
Exchange API documentation.

Investors1

A fund whose thesis fits

Approach MOST via 4sell

MOST Accelerator Fund is based in Kazakhstan and backed 4sell in the network, an Astana Hub resident like Hi Doctor's pilot context.

25%confidence

Evidence from the records

  • “MA7 Ventures, MOST Accelerator Fund, Axiom Capital”
  • “Pilot among the 10 projects of the Astana Smart City program (Astana Hub / Astana Innovations)”
If it works
A regional first cheque.
First step
Ask 4sell's founders for an introduction.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Investors that fit

Investor in 4sell's US$0.4M pre-seed (Kazakhstan, US$4M valuation); thesis, geography and team are undocumented.

Kyrgyz AI medical simulation in the Astana Smart City pilot: Central Asian AI-core, self-funded.

30%confidence

Evidence from the records

  • “AI-based medical education and clinical simulation”
  • “Pilot among the 10 projects of the Astana Smart City program”
Intro path
4sell (Axiom portfolio)
First step
Ask 4sell for an intro to Axiom.

Kazakh accelerator fund with no profile in our data; co-invested in 4sell's $400K pre-seed.

Kyrgyz AI medical education — Central Asia.

30%confidence

Evidence from the records

  • “Kazakhstan”
  • “AI-based medical education and clinical simulation”
  • “Pilot among the 10 projects of the Astana Smart City program (Astana Hub / Astana Innovations)”
Intro path
Founder-to-founder intro via 4sell (network portfolio company of MOST Accelerator Fund).
First step
Apply.

Investor with no public profile in our data; joined 4sell's $400K pre-seed at a $4M valuation in Kazakhstan.

Kyrgyz AI medical simulation — Central Asian AI.

25%confidence

Evidence from the records

  • “4sell”
  • “AI-based medical education and clinical simulation”
  • “Pilot among the 10 projects of the Astana Smart City program (Astana Hub / Astana Innovations)”
Intro path
Founder-to-founder intro via 4sell (network portfolio company of MA7 Ventures).
First step
Ask 4sell for an introduction.

Investor with no public profile in our data; wrote a $110K pre-seed cheque into Kazakh smart-insole startup MiraiTech.

Kyrgyz AI medical education — Central Asia health.

25%confidence

Evidence from the records

  • “MiraiTech”
  • “AI-based medical education and clinical simulation”
  • “Pilot among the 10 projects of the Astana Smart City program (Astana Hub / Astana Innovations)”
Intro path
Founder-to-founder intro via MiraiTech (network portfolio company of JAS Ventures).
First step
Ask MiraiTech for an introduction.

Seedstars' Geneva seed fund ($20M first close) investing $150K-$250K very early in scalable emerging-market startups.

Kyrgyz physician-founded medical AI piloting in Astana Smart City: emerging-market health, self-funded and early.

25%confidence

Evidence from the records

  • “AI-based medical education and clinical simulation”
  • “Pilot among the 10 projects of the Astana Smart City program”
Intro path
Astana Hub (Hi Doctor investor).
First step
Revisit after paid pilots.

Investment analysis

4.0D

Grade D

Rank 89 of 151

Disruption4.0/10
Business model3.0/10
Market5.0/10
Risk(lower is better)7.0/10

Global score = mean of disruption, model, market and (11 − risk). Last updated 21 Nov 2026.

Too early and too local.

Disruption

4/10

AI ecosystem for doctors: an assembly of existing tools.

Business model

3/10

Astana Smart City pilot and tests at a simulation center, no proven revenue.

Market

5/10

Score 5/10: TAM $2.06bn → base 4; scalability 7/10 (0); used in Kyrgyzstan and Kazakhstan (Astana pilot) (+1).

Risk

7/10

Lower is better

High risk: self-funded, health regulation and international competition.

Strengths

  • Physician founder
  • Institutional pilot

Risks

  • No revenue
  • Narrow market

Funding

Undisclosed, no funding
  1. 2024

    Accelerator (AP Kyrgyzstan Unicorner application)not disclosed

    AP Kyrgyzstan Unicorner

  2. non précisée

    Pilot program (Smart City Astana Hub / Astana Innovations); Dive into Silicon Valley selectionnot disclosed

    Astana Hub

Amount used in the study. Self-funded according to the founder.

Note. no public funding round found (self-funded according to the founder)

Identity and Kyrgyzstan regional win confirmed (Startup World Cup LinkedIn post; co-organized by Startup Lab 119 and Turkic American Angel Network). Description broadened: 2025 press coverage mainly describes tools for doctors, with the virtual patient simulation then in development. Year: tool created in 2019 (start-up monetized in 2024) — the previous value of 2025 was not sourced. Self-funded according to the founder (April 2025). Website not found.

Team

  • Nursultan Masalbekov

    Founder & CEO

    Physician (Bishkek) who started building the tool in 2019 to digitize his own clinical practice; monetization from 2024 (AP Kyrgyzstan Unicorner accelerator).

Sources

Regional final
Kyrgyzstan (regional final 2026, winner)
Identification confidence
high
  1. 1linkedin.com/posts/startup-world-cup_startupworldcup-swc2026-swckyrgyzst
  2. 2instagram.com/hidoctor_ai/
  3. 3the-tech.kz/kak-ii-startap-hidoctor-iz-kyrgyzstana-pomogaet-vracham-vyy

From the open study Startup World Cup 2026 by TIBOK, based on public sources, verified in November 2026. Scores are an analyst's judgment on an explicit grid, not the jury's.

Wall

Wall

No posts yet